Public awareness and knowledge of blood donation eligibility and deferral criteria: Fostering a culture of donation and advancing equity
Transfusion · 23.07.2026
DOI: 10.1111/trf.70336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 23.07.2026. Verfasst von N Joëlle Kasongo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Blood Services.
Abstract (Originalsprache)
Background
In Canada, blood operators permanently defer individuals with a history of malaria to prevent transfusion‐transmitted malaria. While protective, this policy raises equity concerns, particularly for individuals requiring frequent transfusions, including those living with sickle cell disease. This study examined public awareness of donor screening criteria, perceived barriers to donation, willingness to donate, and views on potential changes to malaria deferral policies. Study Design and Methods A mixed‐methods community based study was conducted using a national survey. The survey assessed awareness of donor screening criteria, perceived barriers, and willingness to donate before and after anticipated malaria policy changes. Quantitative results were stratified by malaria endemicity (high, moderate, and low region groups). Results are presented as proportions with 95% confidence intervals. Open text responses were analyzed using categorical thematic coding.
Results
Overall awareness of donor screening criteria was high at 67.5% ( n = 385). Across endemicity groups, most participants reported no concerns regarding blood safety if a malaria test were implemented. A small subset of respondents ( n = 113, 29.3%) expressed concerns, primarily related to testing reliability and blood handling processes. Willingness to donate remained unchanged for under half the respondents, with 38%–44% reporting willingness to donate pre‐implementation and post‐implementation. Notably, 13%–21% of those unwilling to donate before reported increased willingness to donate.
Discussion
Safety concerns were limited, and malaria screening was not perceived as a barrier to donation. These findings support implementation of malaria nucleic acid testing and removal of lifetime deferral policies, highlighting opportunities to expand donor eligibility while maintaining blood safety.
Autor:innen und Institutionen
- Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Li Ka Shing Institute of Virology, Edmonton, Alberta, Canada.
- Department of Health Sciences, Carleton University, Ottawa, Ontario, Canada.
- Donation Policy and Studies, Canadian Blood Services, Ottawa, Ontario, Canada.
- Department of Sociology and Anthropology, Carleton University, Ottawa, Ontario, Canada.
- Sickle Cell Disease Association of Canada, Toronto, Ontario, Canada.
ORCID-Profile: Jennie Haw, Carmen L Charlton
Förderung
- Canadian Blood Services
Zitieren
APA
Kasongo, N. J., Haw, J., Joshua, C., Tinga, B., & Charlton, C. L. (2026). Public awareness and knowledge of blood donation eligibility and deferral criteria: Fostering a culture of donation and advancing equity. Transfusion. https://doi.org/10.1111/trf.70336
Vancouver
Kasongo NJ, Haw J, Joshua C, Tinga B, Charlton CL. Public awareness and knowledge of blood donation eligibility and deferral criteria: Fostering a culture of donation and advancing equity. Transfusion. 2026. doi:10.1111/trf.70336
BibTeX
@article{Kasongo2026,
author = {Kasongo, N Joëlle and Haw, Jennie and Joshua, Courtney and Tinga, Biba and Charlton, Carmen L},
title = {Public awareness and knowledge of blood donation eligibility and deferral criteria: Fostering a culture of donation and advancing equity},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70336}
}
EUVIMED